Fortress Biotech and its subsidiary Helocyte have announced the dosing of the first subject in a multi-centre Phase II trial ...

Possible safety signals for transverse myelitis — spinal cord inflammation — after viral-vector vaccines were identified in ...

“Although individual vaccines have been developed and approved for use in humans against SARS-CoV-2 and influenza viruses, ...

An inhalable version of a single-shot, adenovirus-based viral vector vaccine might provide a new option for COVID-19 vaccination. In October 2021, the World Health Organization set a target for ...

AZD1222, developed by the University of Oxford and licenced to AstraZeneca, was among the first vaccines created to protect against COVID-19. A non -replicating viral vector vaccine which was ...

Combine the virus genes with vectors. To make your genetic vaccine, you'll use vectors. Vectors are agents that are able to enter and instruct cells to create proteins based on the vector's DNA code.

"The Chinese poultry lineage may have experienced more vaccine-driven selection compared to other lineages," the researchers wrote.

Notable examples include the development of Ebola and COVID-19 vaccines using adenoviral and other viral vector platforms. As the field of viral vector technology continues to evolve, several areas of ...

and those products or vaccines can be used effectively, GeoVax’s viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its ...

Suresh Mittal, Distinguished Professor of Virology in the College of Veterinary Medicine, presented “Universal Influenza Vaccine — An Aspiration or Reality?” at the Westwood Lecture Series on Jan. 28.

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies, today highlighted that it is committed to playing a pivotal role in reinforcing ...